Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab
Clinical trial NCT05037396 · COMPLETED
Trial details
- NCT number
- NCT05037396
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-05
- Primary completion
- 2020-08-01
- Enrollment
- 9457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.